Skip to main content

Table 5 Characteristics of patients mean values are reported, with standard deviation in parentheses; statistical significance for p < 0.05

From: A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”

Entry

Group A n = 150

Group B n = 150

p-value

Positive hCG n (%)

39 (26)

44 (29)

ns

Implantation rate n/n (%)

45/234 (19.2)

49/222 (22)

ns

Abortion rate n (%)

7(18.8)

6 (13.6)

ns

Ongoing pregnancy/Started patient (%)

32/150 (21)

38/150 (25)

ns

Twin pregnancy n (%)

6 (16)

5 (15.6)

ns